Panel Discussion with representatives from across the pharmaceutical sector
The pharmaceutical sector is under increasing pressure to decarbonise supply chains, to mitigate the impacts of medicines on the environment, and to shift the balance of benefits more equally across patients, planet and profits. The stakes are high for all involved. Progress is variable. Industry, regulators, healthcare providers, professional organisations and citizen groups all have potential roles to play. But what is the way forward? How can pharmaceutical companies work differently in the interests of planetary health? What incentives and levers are there for change, and across global supply chains? And how can we make this all happen rapidly, and at scale? In this panel, representatives from across the pharmaceutical sector will come together to debate these pressing issues, to consider the urgent steps needed to bring about change and how, with urgency, to make them a reality.

Speakers
Moderator: Amy Booth, Sustainable Health Care Module Co-lead
Mark Wilson, Executive Director, Health Care Without Harm Europe
Martin Chilcott, Founder and CEO, Manufacture 2030
Liz Breen, Professor of Health Service Operations, Faculty of Life Sciences University of Bradford
Chris Winchester, CEO, Oxford PharmaGenesis